Il s'agit d'une technologie liposomale
doi: 10.3389/fncel.2025.1601366 Received 27 March 2025 Accepted 10 June 2025 Published 04 July 2025 Volume 19 - 2025 Edited by Marco Cambiaghi, University of Verona, Italy Reviewed by Enoch Luis, National Council of Science and Technology (CONACYT), Mexico Mingzi Zhang, University of Southern California, United States Updates Copyright 2025 Bessetti and Litwa
Blanco-Mguez A, Beghini F, Cumbo F, McIver LJ, Thompson KN, Zolfo M, et al
This peptide has been shown to accelerate the healing of wounds, tendons, and ligaments, reduce inflammation, and protect organs, including the heart and stomach
With respect to transporters, SLCO1B1, SLCO2B1, and ABCG2 are good candidates, whereas proper functional characterization of ABCB1 is necessary prior to applying any strong conclusions of their association with SIM
Closing: The Clinic Takeaway on AOD 9604 in Miami AOD 9604 is a genuinely interesting fat metabolism peptide with a modest evidence base and a clear regulatory caveat: it is not FDA-approved, and the research supports it as a possible adjunct rather than a miracle
